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a  b  s  t  r  a  c  t
The mechanisms contributing to persistence of coagulase-negative staphylococci are
diverse; to better understanding of their dynamics, the characterization of nosocomial iso-
lates  is needed. Our aim was to characterize phenotypic and molecular characteristics of
Staphylococcus epidermidis and Staphylococcus haemolyticus human blood isolates from two ter-
tiary care hospitals in Mexico, the Hospital Universitario in Monterrey and the Hospital Civil
in  Guadalajara.
Antimicrobial susceptibility was determined. Bioﬁlm formation was assessed by crys-
tal  violet staining. Detection of the ica operon and Staphylococcal Cassette Chromosome
mec typing were performed by PCR. Clonal relatedness was determined by Pulsed-ﬁel gel
electrophoresis and Multi locus sequence typing.
Methicillin-resistance was 85.5% and 93.2% for S. epidermidis and S. haemolyticus, respec-tively. Both species showed resistance >70% to norﬂoxacin, clindamycin, levoﬂoxacin,
ethoxazole, and erythromycin. Three S. epidermidis and two S.trimethoprim/sulfamhaemolyticus isolates were linezolid-resistant (one isolate of each species was cfr+). Most
isolates of both species were strong bioﬁlm producers (92.8% of S. epidermidis and 72.9% of
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E-mail address: elvira garza gzz@yahoo.com (E. Garza-González).
ttp://dx.doi.org/10.1016/j.bjid.2016.05.007
413-8670/© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
420  b r a z j i n f e c t d i s . 2 0 1 6;2  0(5):419–428
S. haemolyticus). The ica operon was ampliﬁed in 36 (43.4%) S. epidermidis isolates. SCCmec
type IV was found in 47.2% of the S. epidermidis isolates and SCCmec type V in 14.5% of S.
haemolyticus isolates. No clonal relatedness was found in either species. Resistance to clin-
damycin, levoﬂoxacin, erythromycin, oxacillin, and cefoxitin was associated with bioﬁlm
production for both species (p < 0.05). A G2576T mutation in 23S rRNA gene was detected
in an S. haemolyticus linezolid-resistant isolate. All linezolid-resistant S. epidermidis isolates
belonged to ST23; isolate with SCCmec type IV belonged to ST7, and isolate with SCCmec
type  III belonged to ST2. This is the ﬁrst report of ST7 in Mexico.
There was a high genetic diversity in both species, though both species shared charac-
teristics that may contibute to virulence.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
“Fray Antonio Alcalde”, a 1000-bed tertiary care teaching hos-Introduction
Coagulase-negative staphylococci (CoNS) are among the main
causative agents of bacteremia.1 Staphylococcus epidermidis
and Staphylococcus haemolyticus are the CoNS species most
frequently isolated from blood.2 These species are often asso-
ciated with infections in immunocompromised patients who
have medical device implants.3 These species persist on med-
ical devices because they can form bioﬁlms, bacterial clusters
that attach to materials such as plastics. Bioﬁlm formation
has been associated with the presence of the ica operon
that encodes for the production of a polysaccharide inter-
cellular adhesin (PIA). This operon contains the icaA, icaB,
icaC, icaD, and icaR genes; expression of these genes have
been found to be involved in bioﬁlm formation.4 Furthermore,
bioﬁlm production has been associated with an increased
resistance to antibiotics.5 CoNS strains may present a high
proportion of resistance to antibiotics,6,7 particularly methi-
cillin resistance, thus complicating the management of these
infections.
Methicillin resistance in Staphylococcus aureus was ﬁrst
reported in 1961.8 Methicillin-resistant S. aureus strains pro-
duce a penicillin-binding protein, known as PBP2a or PBP2′,
that has low binding afﬁnity for -lactams. PBP2a is encoded
by mecA, which is contained within the Staphylococcal Cas-
sette Chromosome mec  (SCCmec).9 Also, methicillin-resistance
has been found in CoNS species more  often than in S.
aureus species isolated from clinical samples.10 To date,
11 types of SCCmec have been described in S. aureus
(http://www.sccmec.org/), and evidence suggests that SCCmec
structures may be more  diverse in CoNS. These various
structures may contain combinations of mec and ccr com-
plexes not described for S. aureus or may contain multiple ccr
complexes.11 Since methicillin-resistance is more  frequent in
CoNS, methicillin-resistant CoNS (MR-CoNS) may serve as a
large reservoir of SCCmec  and may contribute to the formation
of methicillin-resistant S. aureus (MRSA) strains.10
Since CoNS are components of the human skin microbiota,
often endogenous strains are capable of causing infec-
tions in immunocompromised individuals. However, there
are reports of persisting strains in hospital wards.12,13 The
genetic relatedness between these strains has been deter-
mined by Pulsed-Field Gel Electrophoresis (PFGE); a technique
that has been widely used for molecular typing of nosocomiallicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
pathogens. Nevertheless, Multilocus Sequence Typing (MLST),
based on sequencing of conserved housekeeping genes, is
proving to be the most appropriate tool for the study of the
global epidemiology, allowing the comparison of isolates from
different countries and the naming of international clones.
To date, a widely acceptable MLST scheme and database
have been developed for S. epidermidis only but not for S.
haemolyticus.14
The persistence of strains of these species may be due
to their increasing high resistance to antimicrobials, which
may enhance their ﬁtness to hospital environments, includ-
ing linezolid-resistance. At the same time, the production of
bioﬁlm has been associated with antibiotic resistance and
the persistence of the strains in medical devices. Further-
more,  the presence of SCCmec worsens the scenario, since
horizontal transference of these elements may contribute
to antibiotic resistance. Finally, the information of genetic
relatedness would allow us to know the dynamics of transmis-
sion of these infections. We  hypothesized that the presence of
strains with traits such as bioﬁlm formation, high resistance
to antibiotics and diverse SCCmec elements may contribute to
the persistence of these strains. Thus, we  aimed to character-
ize phenotypic and molecular characteristics of S. epidermidis
and S. haemolyticus blood isolates from two Mexican tertiary-
care hospitals, the Hospital Universitario in Monterrey and
the Hospital Civil in Guadalajara, in order to determine dis-
tribution of SCCmec elements, antibiotic resistance, genetic
relatedness, and bioﬁlm formation, as well as to examine its
relationship to drug resistance. Both settings are teaching hos-
pitals that offer a variety of services, educational programs,
a space for clinical research and health-related community
services working as a reference facility for two of the major
metropolitan areas in Mexico.
Materials  and  methods
Hospital  setting  and  identiﬁcation  of  clinical  isolates
This study was performed at the Hospital Civil de Guadalajarapital, with approximately 30,000 admissions annually, located
in Guadalajara, Jalisco, and at the Hospital Universitario “Dr.
José Eleuterio González”, a 450-bed tertiary-care teaching
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ospital with an average hospital admittance rate of 26,500
atients yearly, located in Monterrey, Nuevo León.
Isolates of S. epidermidis (n = 83) and S. haemolyticus (n = 59)
ere collected from the two tertiary care hospitals in Mexico
rom 2006 to 2013. Isolates were obtained from blood cul-
ures. Only one isolate per patient was included. Regarding the
nit ward of precedence, 93/142 (65.5%) of isolates proceeded
rom intensive care units and 90/142 (63.4%) of patients were
ale.
Blood cultures were cultivated using Versa TREK REDOX
ottles and processed using the Versa TREK blood culture sys-
em (Thermo Scientiﬁc, Oakwood Village, OH, USA). Cultures
ere incubated at 37 ◦C and the bottles were monitored for
even days before being discarded as negative. When positive,
he bottle was subcultured in blood agar and incubated at 37 ◦C
p to 72 h. Isolates were identiﬁed by biochemical and molec-
lar methods. For the biochemical method, Sensititre Panels
TREK Diagnostic Systems Inc., Cleveland, OH, USA) were
sed according to the manufacturer’s instructions. For the
olecular method, DNA was obtained by phenol-chloroform
xtraction and species were identiﬁed by multiplex PCR of
he nuc gene fragment as described previously.15 S. epidermidis
TCC 14990 and S. haemolyticus ATCC 29970 were used as the
eference strains. All isolates were stored in Brucella broth con-
aining 15% glycerol at −70 ◦C.
ethicillin-resistance  and  antimicrobial  susceptibility
esting
ethicillin-resistance was evaluated using the cefoxitin disk
est described in the M02-A11 document of the Clinical and
aboratory Standards Institute (CLSI). Minimum inhibitory
oncentration (MIC) ranges, MIC50 and MIC90 were determined
sing the broth microdilution method. Panels from Sensititre
TREK Diagnostic Systems Inc.) were used according to the
anufacturer’s instructions. The antimicrobial agents tested
ere oxacillin, vancomycin, erythromycin, tetracycline, levo-
oxacin, clindamycin, trimethoprim-sulfamethoxazole, and
inezolid. Methicillin-resistance and antimicrobial suscepti-
ility test results were interpreted according to the M100-S24
ocument of the CLSI. S. aureus ATCC 29213 and S. aureus BAA-
4 were used as quality controls.
equencing  of  23S  RNA  gene  and  detection  of  cfr
omain V of 23S rRNA gene was ampliﬁed to identify possi-
le mutations in linezolid-resistant isolates, using the primers
reviously described.16 PCR products were puriﬁed by using a
recipitation protocol with 3 M sodium acetate and absolute
thanol, at −20 ◦C. The precipitate was recovered by centrifu-
ation and washed with 70% ethanol. The precipitate was
issolved in sterile nuclease-free water. The products were
hen sequenced (Macrogen, Korea) and aligned with the cor-
esponding nucleotide sequence from reference strains of S.
ureus and Escherichia coli (GenBank accession numbers X68425
nd AF053966, respectively). Presence or absence of the cfr
ene in the linezolid-resistant isolates was determined as
escribed previously.17 Extraction of plasmid DNA was per-
ormed using an alkaline lysis protocol.6;2 0(5):419–428 421
The  bioﬁlm  formation  assay  and  ampliﬁcation  of  the  ica
operon
Bioﬁlm formation was evaluated by crystal violet staining.
Overnight cultures grown in tryptic soy broth were diluted
1:100 in tryptic soy broth supplemented with 1% glucose or
tryptic soy broth supplemented with 3% NaCl. Each dilu-
tion was dispensed into four wells of ﬂat-bottom polystyrene
plates (Falcon, Franklin Lakes, NJ). After incubation for 24 h at
37 ◦C, the absorbance of planktonic cells was determined at
595 nm.  The broth was eliminated and the wells were washed
twice with sterile PBS (pH 7.3). Bioﬁlms were stained with
Hucker’s crystal violet for 15 min; the stain was removed,
and the wells were washed with sterile deionized water. The
stained bioﬁlms were dissolved in 200 L of 30% acetic acid,
and optical densities (OD) were measured at 595 nm.  Bioﬁlm
formation was evaluated using the cut-off value suggested by
Christensen et al.18 If the OD were less than or equal to 0.120,
we classiﬁed the strain as non-bioﬁlm producer. If the OD was
above  0.240, the strain was classiﬁed as strong bioﬁlm pro-
ducer. Strains with OD greater than 0.120 but less than or equal
to 0.240 were classiﬁed as weak bioﬁlm producers. The bioﬁlm
index (bioﬁlm absorbance/planktonic cell absorbance) was
also calculated, which normalizes for differences in growth
rates.
Genes in the ica operon were detected by multiplex PCR
as described by Arciola et al.19 All ﬁve ica genes, icaA, icaD,
icaB, icaC, and icaR, were tested, and PCR products were visu-
alized on a 2.5% agarose gel stained with 1 mg/mL  of ethidium
bromide.
Detection  of  mecA  and  SCCmec  typing
Ampliﬁcation of mecA and SCCmec typing were performed by
multiplex PCR as described by Zhang et al.20 and Kondo et al.21
The multiplex PCR assay by Kondo et al. contained a modiﬁ-
cation to the primers used to amplify mec complex class C and
ccr complex type 4 and type 5 as described by Ruppé et al.11
Clonal  relatedness
Clonal relatedness of isolates was determined by PFGE as
described previously,10 but with modiﬁcations for CoNS in
running conditions: the pulse times were 1–35 s for 24 h at
200 V. DNA was digested with the restriction enzyme SmaI,
on a CHEF-DRIII instrument (Bio-Rad Laboratories, Hercules,
CA) electrophoresis was performed. Gels were stained with
ethidium bromide and images were obtained using the Lab-
works 4.5 software package. Banding patterns were analyzed
visually, a database was created, and statistical analysis was
performed using the statistical software package SPSS 20.0
(IBM Corporation, Somers, NY).
Multi  locus  sequence  typing  of  S.  epidermidis  isolatesPrimers and conditions were obtained from a previously
described scheme.14 Determination of alleles and sequence
type (ST) were performed using the S. epidermidis MLST
database (http://sepidermidis.mlst.net/).22
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Table 1 – Antimicrobial susceptibility of S. epidermidis and S. haemolyticus isolates.
Antimicrobial S. epidermidis S. haemolyticus
MIC50a
(g/mL)
MIC90b
(g/mL)
Resistant
n  (%)
Susceptible
n  (%)
MIC50a
(g/mL)
MIC90b
(g/mL)
Resistant
n (%)
Susceptible
n  (%)
Oxacillin >0.5 >0.5 72 (86.7) 11 (13.3) >0.5 >0.5 55 (93.2) 4 (6.8)
Vancomycin 2 4 0 (0) 83 (100) 2 2 0 (0) 59 (100)
Erythromycin >4 >4 66 (79.5) 16 (19.3) >4 >4 53 (89.8) 6 (10.2)
Tetracycline ≤2 >8 10 (12) 71 (85.6) ≤2 >8 13 (22.0) 44 (74.6)
Levoﬂoxacin >2 >2 62 (74.7) 18 (21.7) >2 >2 54 (91.5) 4 (6.8)
Norﬂoxacin >8 >8 64 (77.1) 18 (21.7) >8 >8 53 (89.8) 6 (10.2)
Clindamycin >2 >2 68 (81.9) 12 (14.5) >2 >2 53 (89.8) 5 (8.5)
Trimethoprim/
sulfamethoxazole
>2/38 >2/38 60 (72.3) 23 (27.7) >2/38 >2/38 45 (76.3) 14 (23.7)
Linezolid ≤2 4 3 (3.6) 80 (96.4) ≤2 ≤2 2 (3.4) 57 (96.6)
Minimum inhibitory concentration (MIC) ranges, MIC50 and MIC90 were determined using the broth microdilution method. Panels from Sensititre
(TEK Diagnostic Systems Inc.) were used according to the manufacturer’s instructions.
a MIC50, minimal inhibitory concentration for 50% of the isolates.
b MIC90, minimum inhibitory concentration for 90% of the isolates.
Statistical  analysis
The correlation between drug resistance and bioﬁlm pro-
duction was analyzed using a chi-square test and OpenEpi
software version 3.03 (Rollins School of Public Health, Emory
University). A p-value <0.05 was considered signiﬁcant.
Results
Methicillin-resistance  and  antimicrobial  susceptibility
proﬁles
Of the S. epidermidis isolates tested, 85.5% (71/83) were
methicillin-resistant, whereas 93.2% (55/59) of the S. haemolyti-
cus isolates were methicillin-resistant, both by the cefoxitin
disk test. In S. epidermidis, all methicillin-resistant isolates
were also resistant to oxacillin and contained mecA; however,
a methicillin-susceptible isolate was resistant to oxacillin and
contained mecA. In S. haemolyticus, all methicillin-resistant iso-
lates were also resistant to oxacillin and contained mecA.
Resistance to oxacillin, erythromycin, levoﬂoxacin, clin-
damycin, and trimethoprim/sulfamethoxazole was >70% for
both species (Table 1). Twelve percent of the S. epidermidis
isolates were tetracycline-resistant, whereas 22% of the S.
haemolyticus isolates were tetracycline-resistant. Three (3.6%)
of the S. epidermidis and two (3.4%) of the S. haemolyticus isolates
were resistant to linezolid.
Sequencing  of  23S  RNA  gene  and  detection  of  cfr
Analysis of domain V of 23S rRNA in linezolid-resistant
isolates showed a G to T mutation at position 2576 (E. coli num-
bering) in a S. haemolyticus isolate (isolate 2975). Remaining
isolates were negative for mutations in domain V. The cfr gene
was detected in one linezolid-resistant S. epidermidis isolate
(isolate 14565) and one linezolid-resistant S. haemolyticus iso-
late (isolate 9976) (Table 2). Also, plasmid DNA extraction was
performed in cfr-negative isolates in order to determine thepresence of the cfr gene in plasmids. The cfr gene was not
ampliﬁed in this isolates.
All linezolid-resistant isolates, except one S. haemolyticus
isolate, were also resistant to methicillin. None of the isolates
was resistant to vancomycin.
Bioﬁlm  production  and  presence  of  the  ica  operon
Of the S. epidermidis isolates, 77 (92.8%) were strong bioﬁlm
producers, 5 (6%) were weak bioﬁlm producers, and 1 (1.2%)
did not form bioﬁlms in glucose-supplemented broth. In NaCl-
supplemented broth, 72 (86.7%) of the isolates were strong
bioﬁlm producers, 7 (8.4%) were weak bioﬁlm producers, and
4 (4.8%) did not form bioﬁlms.
Similar results were found with the S. haemolyticus iso-
lates; 43 (72.9%) were strong bioﬁlm producers, 12 (20.3%) were
weak bioﬁlm producers, and 4 (6.8%) did not form bioﬁlms
in glucose-supplemented broth. In NaCl-supplemented broth,
30 (50.8%) were strong bioﬁlm producers, 7 (11.9%) were weak
bioﬁlm producers, and 22 (37.3%) did not form bioﬁlms.
Genes within the ica operon were present in 36 (43.4%) of
the S. epidermidis isolates but were not found in any of the
S. haemolyticus isolates. All the ica-positive isolates contained
icaA, icaD, icaC, icaB, and icaR. All but one of the ica-positive iso-
lates produced strong bioﬁlms in the glucose-supplemented
broth. Thirty-two of the 36 ica-positive isolates produced
strong bioﬁlms in the NaCl-supplemented broth. For both
S. epidermidis and S. haemolyticus, an association was found
between strong bioﬁlm production and resistance to nor-
ﬂoxacin, clindamycin, levoﬂoxacin, erythromycin, oxacillin,
and cefoxitin (p < 0.05) when testing bioﬁlm production in the
glucose-supplemented broth.
Detection  of  mecA  and  SCCmec  typing
The mecA gene was found in 72/83 (86.7%) of S. epidermidis iso-
lates and 55/59 (93.2%) of S. haemolyticus isolates. Among the
S. epidermidis isolates containing mecA, 5 (6.9%) were classiﬁed
as SCCmec type III (ccr type 3, class A mec) and 34 (47.2%) were
classiﬁed as type IV (ccr type 2, class B mec). Also, 22 (64.7%)
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Table 2 – SCCmec  typing, susceptibility proﬁle and bioﬁlm production of linezolid-resistant isolates.
Isolate Species SCCmec typing Susceptibility proﬁlea Linezolid resistanceb Bioﬁlm production
mecA  mec class ccr type FOX OX TET MIC (g/mL) cfr Glucose NaCl ica operon
14583 S. epidermidis +  A 3 + 5 R  R S 8 Negative Strong Strong Negative
14565 S. epidermidis +  A 3 + 5 R R I >32 Positive Strong Strong Positive
12701 S. epidermidis + A 3 R R S 8 Negative Strong Strong Positive
9976 S. haemolyticus − NA NA S S S 8 Positive NP NP Negative
2975 S. haemolyticus + NT NT R R R 32 Negative Strong NP Negative
NA, not applicable; NT, not typable; FOX, cefoxitin; OX, oxacillin; TET, tetracycline; MIC, minimum inhibitory concentration; NP, non-producer.
Methicillin-resistance was evaluated using the cefoxitin disk test, minimum inhibitory concentration was determined using the broth microdilu-
tion method. Bioﬁlm formation was assessed by crystal violet staining. Ampliﬁcation of the ica operon, mecA and SCCmec typing were performed
by multiplex PCR.
a All isolates were resistant to norﬂoxacin, clindamycin, levoﬂoxacin, trimethoprim/sulfamethoxazole, and erythromycin. All isolates were
susceptible to vancomycin.
b Mutation G2576T was found in isolate 2975.
Table 3 – SCCmec  typing, resistance proﬁle, and bioﬁlm production of S. epidermidis isolates.
No. of isolates SCCmec typing Resistance proﬁlea
n (%)
Bioﬁlm productionb
n (%)
mec class ccr type SCCmec NOR CLI TET LEV LZD SXT ERY Glucose NaCl
34 B 2 IV 30 (88) 30 (88) 3 (8.8) 30 (88) 0 (0) 25 (74) 30 (88) 33 (97) 30 (88)
5 A 3 III 5 (100) 4 (80) 0 (0) 5 (100) 1 (20) 4 (80) 4 (80) 5 (100) 4 (80)
3 A 1 New 3 (100) 3 (100) 2 (67) 3 (100) 0 (0) 2 (67) 3 (100) 3 (100) 2 (67)
1 A 5 New 1 (100) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100) 1 (100) 1 (100)
1 A 1 + 2 Variant 0 (0) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) 1 (100) 0 (0)
5 B 1 + 2 Variant 5 (100) 5 (100) 1 (20) 5 (100) 0 (0) 4 (80) 5 (100) 5 (100) 4 (80)
1 A 2 + 3 Variant 1 (100) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100) 1 (100) 1 (100)
7 A 3 + 5 Variant 7 (100) 7 (100) 1 (14) 7 (100) 2 (29) 7 (100) 7 (100) 7 (100) 7 (100)
5 B 2 + 5 Variant 3 (60) 5 (100) 1 (20) 2 (40) 0 (0) 3 (60) 4 (80) 5 (100) 5 (100)
2 A 2 + 4 Variant 2 (100) 2 (100) 0 (0) 2 (100) 0 (0) 2 (100) 2 (100) 2 (100) 2 (100)
1 A 3 + 4 Variant 1 (100) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100) 0 (0) 1 (100)
1 B 2 + 4 Variant 1 (100) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100) 1 (100) 1 (100)
2 A 1 + 4 + 5 Variant 0 (0) 2 (100) 0 (0) 0 (0) 0 (0) 2 (100) 2 (100) 2 (100) 1 (50)
1 NT 2 + 5 NT 1 (100) 0 (0) 0 (0) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100)
1 NT 2 NT 1 (100) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100) 1 (100) 1 (100)
2 A NT NT 2 (100) 2 (100) 1 (50) 1 (50) 0 (0) 2 (100) 2 (100) 2 (100) 2 (100)
NT, not typeable; CLI, clindamycin; TET, tetracycline; LEV, levoﬂoxacin; LZD, linezolid; SXT, trimethoprim/sulfamethoxazole; ERY, erythromycin.
Methicillin-resistance was evaluated using the cefoxitin disk test, minimum inhibitory concentration was determined using the broth microdi-
lution method. Bioﬁlm formation was assessed by crystal violet staining. Ampliﬁcation of the ica operon and SCCmec typing were performed
by multiplex PCR.
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Sa All isolates were resistant to cefoxitin and oxacillin. All isolates we
b Strong producers.
f the SCCmec type IV isolates were subtyped as SCCmec IVa
nd one (2.9%) was subtyped as SCCmec IVb. The remaining
solates could not be subtyped to SCCmec IVc or IVd. S. epi-
ermidis with SCCmec type IV were more  likely to be resistant
o norﬂoxacin and erythromycin. The ﬁve SCCmec type III iso-
ates were subtyped as subtype III.1. Among the remaining
solates, more  diverse SCCmec combinations were found; four
solates (5.6%) had ccr and mec combinations not included in
he classiﬁcation scheme for S. aureus,  and 23 (31.9%) isolates
mpliﬁed for more  than one ccr complex. Four (5.6%) of the
solates could not be typed since mec or ccr complexes were
ot ampliﬁed in these strains (Table 3).Of the S. haemolyticus isolates containing mecA, only 8
14.5%) isolates could be typed and they were classiﬁed as
CCmec  type V (ccr complex type 5, mec complex class C2).
CCmec  subtype V.1 was not detected. Four (7.3%) isolatessceptible to vancomycin.
contained more  than one ccr complex. 43 (78.1%) of the isolates
did not contain mec complex, but 13 (26.6%) of them contained
ccr. More than half of the isolates (30/55, 54.5%) did not contain
ccr or mec complexes (Table 4).
Clonal  diversity
SmaI restriction digestion of 76 S. epidermidis isolates gener-
ated 7–17 fragments. For seven of the isolates, three or fewer
fragments were generated. Therefore, these isolates were not
considered for further analysis. A total of 75 different restric-
tion patterns with similarities ranging from 0 to 95% were
obtained. Only two of the isolates (isolates 11566 and 11567)
were 95% homologous and were considered as a clone (Fig. 1).
Both strains were classiﬁed as SCCmec type III by the method-
ology described by Zhang et al., but were classiﬁed as variants
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Table 4 – SCCmec  typing, resistance proﬁle, and bioﬁlm production of S. haemolyticus isolates.
No. of isolates SCCmec typing Resistance proﬁlea Bioﬁlm productionb
mec class ccr type SCCmec CLI TET LZD ERY Glucose NaCl
8 C2 5 V 7 (88) 3 (38) 0 (0) 7 (88) 7 (88) 4 (50)
1 C2 1 + 2 + 5 Variant 0 (0) 0  (0) 0  (0) 0 (0) 1 (100) 0 (0)
3 C2 1 + 4 + 5 Variant 3 (100) 3 (100) 0 (0) 3 (100) 3 (100) 2 (67)
12 NT 4 NT 10 (83) 3 (25) 0 (0) 11 (92) 8 (67) 5 (42)
1 NT 5 NT 1 (100) 1 (100) 0 (0) 1 (100) 1 (100) 0 (0)
30 NT NT NT 30 (100) 3 (10) 1 (3) 30 (100) 23 (77) 18 (60)
NT, not typeable; CLI, clindamycin; TET, tetracycline; LZD, linezolid; ERY, erythromycin.
Methicillin-resistance was evaluated using the cefoxitin disk test, minimum inhibitory concentration was determined using the broth microdi-
lution method. Bioﬁlm formation was evaluated by crystal violet staining. Ampliﬁcation of the ica operon and SCCmec typing were performed
by multiplex PCR.
a All isolates were resistant to cefoxitin, oxacillin, norﬂoxacin, levoﬂoxacin and trimethoprim/sulfamethoxazole. All isolates were susceptible
to vancomycin.
b Strong producers.
by Kondo et al. methodology, since they also ampliﬁed ccrC.
Both were resistant to norﬂoxacin, clindamycin, levoﬂoxacin,
trimethoprim/sulfamethoxazole, erythromycin, oxacillin, and
cefoxitin, but susceptible to linezolid and vancomycin. Also,
both strains were classiﬁed as strong bioﬁlm producers by
both supplemented broths and proceed from intensive care
units.
SmaI restriction digestion of the S. haemolyticus isolates
generated 7–15 fragments, and 57 different patterns were pro-
duced. Isolates 9990 and 9982 were considered clone A, and
isolates 14425 and 14162 were considered clone B (Fig. 2). Both
clones had 95% of similarity. The remaining isolates had sim-
ilarities of 60% or less.
Isolates 9990 and 9982 were classiﬁed as non-typable
SCCmec. Both were resistant to clindamycin, levoﬂoxacin,
trimethoprim/sulfamethoxazole, erythromycin, oxacillin, and
cefoxitin. Also, both strains were classiﬁed as strong bioﬁlm
producers by NaCl-supplemented broths and proceed from
intensive care units. Isolates 14425 and 14162 were classi-
ﬁed as SCCmec  type V. Both were resistant to norﬂoxacin,
clindamycin, levoﬂoxacin, trimethoprim/sulfamethoxazole,
erythromycin, oxacillin, and cefoxitin. Also, both strains were
classiﬁed as strong bioﬁlm producers by both supplemented
broths and proceed from intensive care units.
MLST  typing
Five S. epidermidis isolates were chosen to be analyzed by MLST:
the linezolid-resistant isolates, an isolate representative of the
group harboring SCCmec type IV, and an isolate representa-
tive of the group harboring SCCmec type III. MLST analysis
showed that all the linezolid-resistant S. epidermidis isolates
(n = 3) belonged to ST23 while the isolate with SCCmec type IV
and the isolate with SCCmec type III belonged to ST7 and ST2,
respectively.Discussion
CoNS infections are associated with high antimicrobial resis-
tance, which makes them difﬁcult to treat. In this study, weanalyzed S. epidermidis and S. haemolyticus human blood iso-
lates for bioﬁlm formation, antimicrobial resistance, SCCmec
type, and clonal diversity.
We identiﬁed three linezolid-resistant S. epidermidis and
two linezolid-resistant S. haemolyticus isolates. Four of these
were also methicillin-resistant. Linezolid is a synthetic oxa-
zolidinone that inhibits protein synthesis by binding to
ribosomal peptidyl transferase, and it is recommended to treat
multidrug-resistant Gram-positive infections. Although line-
zolid resistance is rare (<1% in S. aureus and <2% in CoNS), the
emergence of linezolid-resistant strains is a serious healthcare
concern.23 In the Hospital Civil in Guadalajara, linezolid is the
most commonly used antibiotic for nosocomial pneumonia,
surgical wound infections, and is also used for bloodstream
infections not associated with catheter. In order to reduce the
spreading of linezolid-resistant strains a stewardship antibi-
otic consumption program limiting linezolid use has been
implemented.
In two of the isolates, linezolid-resistance was associ-
ated with the presence of the cfr gene, which encodes for
an adenine methyltransferase that modiﬁes the adenosine at
position 2503 in 23S rRNA. cfr also confers resistance to pheni-
col compounds, lincosamide, oxazolidinone, pleuromutilin,
and streptogramin A.24 cfr has primarily been found on plas-
mids in S. epidermidis and S. haemolyticus isolates,25,26 but can
also be found on the chromosome as a result of the activities
of transposons and insertion sequences.27 The presence of cfr
on mobile genetic elements, which may carry additional resis-
tance genes, probably facilitates cfr dissemination. The two
cfr-containing isolates had different MIC values for linezolid;
isolate 9976 had an MIC of 8 g/mL, whereas isolate 14565
had an MIC > 32 g/mL. These differences suggested the pres-
ence of additional resistance mutations in isolate 14565, so we
sought for mutations in domain V of 23S rRNA in all linezolid-
resistant isolates. However, only isolate 2975 harbored the
G2576T mutation, which is the most frequently reported.28
This isolate had an MIC of 32 g/mL and no cfr gene. Linezolid-
resistance can also be conferred by mutations in ribosomal
proteins L3 and/or L4.29 Our linezolid-resistant isolates should
be analyzed further to identify additional mutations explain-
ing the differences in MIC.
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In Mexico, S. epidermidis STs 2, 23, 46, 61, 71, and 82 have
een reported.30 The three linezolid-resistant S. epidermidis
solates analyzed belonged to ST23. Linezolid-resistance has
een reported in the ST23 clone. In a study from Italy, clinical
solates from blood and cerebrospinal ﬂuid were analyzed. The
ost frequently ST found in linezolid-resistant strains were
T23; also, almost the half of the ST23 strains were cfr positive
22/50), which suggested an association between the genetic
ackground with the cfr gene.31 ST23 has also been reported in
rgentina, Germany, Greece, Hungary, Iceland, Poland, Portu-
al, United States and Uruguay (http://sepidermidis.mlst.net).
One of our isolates was ST2. Linezolid-resistant strains
elonging to ST2 have been described in a Brazilian tertiary-
are hospital in isolates from skull, blood, and catheter
ultures.32 ST2 has also been described in Germany, Argentina,
taly, Poland, Spain, Mexico, Cape Verde, Denmark, Greece, epidermidis isolates.
Hungary, Uruguay; Bulgaria and Colombia, Japan, Nether-
lands, and United States. (http://sepidermidis.mlst.net). In
Mexico, Juarez-Verdayes et al. analyzed isolates from healthy
skin, healthy conjunctiva, and ocular infections; ST2 lin-
eage was the most frequent among the isolates (50% for
healthy skin, 25% for healthy conjunctiva and 46.5% for ocu-
lar infections).33 Similarly, Flores-Paez et al. reported ST2 and
ST23 from isolates from ocular infections.34 None of ST23 or
ST2 has been previously reported from sterile sites in Mex-
ico. To the best of our knowledge S. epidermidis ST7 has not
been reported in Mexico. ST7 has been reported in isolates
from catheter-related bloodstream infections35 and prosthetic
valve endocarditis.14Both S. epidermidis and S. haemolyticus have been shown to
be strong bioﬁlm producers, and the ica operon has been asso-
ciated with bioﬁlm production in S. epidermidis.36 We found
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the ica operon to be present in 36 of the S. epidermidis iso-
lates, and 35 of these isolates were strong bioﬁlm producers.
On the other hand, the ica operon was not found in any of
the S. haemolyticus isolates; this is consistent with a report by
Fredheim et al. in which nearly all of their S. haemolyticus iso-
lates were ica-negative.37 Although S. haemolyticus has been
associated with ica-independent bioﬁlm formation, a report by
Pereira et al. showed that 58% of their isolates harbored icaA.38
Genes such as aap, bap, bhp have been shown to be involved
in ica-independent bioﬁlm formation.4 Moreover, studies on
bioﬁlm detachment have shown that PIA is not a major com-
ponent of S. haemolyticus bioﬁlms.37
All three linezolid-resistant S. epidermidis isolates were
strong bioﬁlm producers, and two were positive for the ica
operon. Bioﬁlm formation has long been associated with
antibiotic resistance, and increased MICs have been linked
to the presence of bioﬁlms.39 One S. haemolyticus linezolid-
resistant isolate was a strong bioﬁlm producer, but neither
S. haemolyticus linezolid-resistant isolate contained the ica
operon. Resistance to norﬂoxacin, clindamycin, levoﬂoxacin,
erythromycin, cefoxitin, and oxacillin were associated with
strong bioﬁlm production (p < 0.05) for both the S. epidermidis
and S. haemolyticus isolates.
As previously described, SCCmec type IV, especially SCCmec
type IVa, was frequently found (47.2%) among the S. epidermidis
isolates. This frequency has been found among isolates from
both inpatients and carriers. In a study that analyzed 44 blood
isolates, SCCmec  type IV was found at a frequency of 36%,40 1 6;2  0(5):419–428
whereas SCCmec type IVa was found at a frequency of 65%
among healthy subjects.41 Wisplinghoff et al. suggested that
genetic information was transmitted between S. epidermidis
and S. aureus since SCCmec IV sequences from both species
were >98% homologous.40 Transmission of SCCmec  between
these species may lead to an increase in beta-lactam antibiotic
resistance in S. aureus;  currently, methicillin-resistance in S.
aureus is not as high as in CoNS.
In this study, we found several combinations of mec  and
ccr complexes in S. epidermidis. Only two SCCmec types (IV
and III) were identiﬁed. The other S. epidermidis isolates had
mec and ccr combinations distinct from the 11 SCCmec  types
reported to date or could not be typed. A problem with ampli-
ﬁcation of more  than one ccr complex is that it is unknown
whether the ampliﬁed ccr complexes are located within the
same SCCmec.11,42
In S. haemolyticus isolates the only SCCmec  found was
SCCmec type V, and it has been found at frequencies as high as
55%.6,11 Similar to the transfer of SCCmec type IV from S. epi-
dermidis to S. aureus,  SCCmec type V may be transferred from
S. haemolyticus to S. aureus.  Notably, we  found that most of the
S. haemolyticus isolates could not be typed. Likewise, Barros
et al.6 reported that 43% (24 isolates) of their S. haemolyticus
isolates could not be typed. There appears to be great SCCmec
diversity among S. haemolyticus isolates.
Despite being commensals, both S. epidermidis, and S.
haemolyticus have been found to be clonal, particularly S.
haemolyticus.7 However, only a clone composed of two  S. epi-
dermidis isolates was found. In addition, two clones with two
strains or S. haemolyticus each one were detected in this study.
Thus, the hypothesis of clonal transmission at the two  source
hospitals is discarded. Since both species are components of
the normal microbiota, it is likely that the infections were
endogenous.
The actual knowledge of the molecular epidemiology of
both species includes an extremely high genetic diversity and
recombination. PFGE is mostly useful for an outbreak or short-
term epidemiological investigations and may not detect clonal
relatedness in isolates recovered through the years. On the
contrary, MLST is more  useful, particularly for the S. epidermidis
isolates since it allows to determine their genetic backgrounds
and to compare to those previously described from other
countries. Due to the relevance of the linezolid-resistant iso-
lates, MLST analysis was considered for these isolates.
In conclusion, this study is the ﬁrst performed in Mexico
that characterizes bioﬁlm production, antimicrobial suscep-
tibility, SCCmec and clonal relatedness of S. epidermidis and
S. haemolyticus blood isolates. Both species were found to be
highly resistant to antibiotics. We  also detected linezolid-
resistance, which is a concern for infection control practices.
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